Drugplain

Sodium chloride 9 mg/mL

SODIUM CHLORIDE · INJECTION, SOLUTION · Fresenius Kabi USA, LLC

10 Recalls on RecordCurrently in Shortage
Plain English

Sodium chloride is a injection, solution containing sodium chloride at 9 mg/mL, taken intravenous. Manufactured by Fresenius Kabi USA, LLC.

Key Facts

Brand Name
Sodium chloride
Generic Name
SODIUM CHLORIDE
NDC Code (Product)
63323-623
Manufacturer
Fresenius Kabi USA, LLC
Strength
9 mg/mL
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS
Marketing Status
Application #
ANDA207310
Marketing Start
09/19/2017

Recall History

10 Recalls on Record
Class II05/05/2016

Pharmedium Services, LLC

Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

TerminatedVoluntary: Firm initiated
Class II07/14/2017

SCA Pharmaceuticals

Lack of Assurance of Sterility; product has the potential to leak.

TerminatedVoluntary: Firm initiated
Class II07/20/2023

SCA Pharmaceuticals

cGMP deviations: due to shipment of rejected units.

TerminatedVoluntary: Firm initiated
Class II07/25/2022

SterRx, LLC

Lack of Assurance of Sterility

TerminatedVoluntary: Firm initiated
Class II11/09/2023

SCA Pharmaceuticals, LLC

Lack of Assurance of Sterility

TerminatedVoluntary: Firm initiated
Class II07/14/2017

Cantrell Drug Company

Lack of Sterility Assurance.

TerminatedVoluntary: Firm initiated
Class II07/17/2015

Pharmedium Services, LLC

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

TerminatedVoluntary: Firm initiated
Class I02/03/2017

SCA Pharmaceuticals

Presence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.

TerminatedVoluntary: Firm initiated
Class II06/17/2016

Teva North America

CGMP Deviations

TerminatedVoluntary: Firm initiated
Class II07/07/2023

SterRx, LLC

Lack of Assurance of Sterility

TerminatedVoluntary: Firm initiated

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

drug ineffective18,605 reports
off label use15,836 reports
seizure10,474 reports
nausea10,204 reports
fatigue9,662 reports
pyrexia8,664 reports
dyspnoea8,652 reports
headache8,301 reports
vomiting8,102 reports
diarrhoea7,914 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

INDICATIONS AND USAGE This sterile, nonpyrogenic electrolyte solution is indicated for all general irrigation, washing, rinsing and dilution purposes including blood cell washing (when used in conjunction with automated intraoperative blood salvaging equipment).

Dosage & Administration

DOSAGE AND ADMINISTRATION The dose is dependent upon the capacity or surface area of the structure to be irrigated and the nature of the procedure. When used as a diluent or vehicle for other drugs, the manufacturer's recommendations should be followed. For use in cell washing, the manufacturer's recommendations for blood salvaging and red cell processing should be followed. Drug Interactions Additives may be incompatible. Consult with pharmacist, if available. When introducing additives, use aseptic technique, mix thoroughly and do not store. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution container permits. See PRECAUTIONS .

Warnings

WARNINGS FOR IRRIGATION ONLY. NOT FOR INJECTION. Entry of a hypotonic solution into the circulation may cause hemolysis. Irrigating fluids have been demonstrated to enter the systemic circulation in relatively large volumes; thus, each of these irrigations must be regarded as a systemic drug. Absorption of large amounts can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, overhydration, congested states or pulmonary edema. The risk of dilutional states is inversely proportional to the electrolyte concentrations of administered parenteral solutions. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentrations of such solutions. Do not heat over 66° C (150° F).

Contraindications

CONTRAINDICATIONS NOT FOR INJECTION BY USUAL PARENTERAL ROUTES. An electrolyte solution should not be used for irrigation during electrosurgical procedures.

Adverse Reactions

ADVERSE REACTIONS Possible adverse effects arising from the irrigation of body cavities, tissues, cells or indwelling catheters and tubes are usually avoidable when proper procedures are followed. Displaced catheters or drainage tubes can lead to irrigation or infiltration of unintended structures or cavities. Excessive volume or pressure during irrigation of closed cavities may cause undue distension or disruption of tissues. Accidental contamination from careless technique may transmit infection. Should any adverse reaction occur, discontinue the irrigant, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.

Frequently Asked Questions

What is Sodium chloride used for?

Sodium chloride contains SODIUM CHLORIDE. It is a injection, solution taken intravenous. Consult your doctor for specific uses.

Is Sodium chloride a controlled substance?

Sodium chloride is not classified as a controlled substance by the DEA.

What is the generic name for Sodium chloride?

The generic name for Sodium chloride is SODIUM CHLORIDE. There are 12 other brand versions of SODIUM CHLORIDE.

What is the NDC code for Sodium chloride 9 mg/mL?

The NDC (National Drug Code) for Sodium chloride 9 mg/mL is 63323-623, listed by Fresenius Kabi USA, LLC.